Prevalence of oral candida infections in diabetic patients

Bahrain Medical Bulletin

Volumn 28, Issue 1, 2006, Pages 12-17

  Abu Elteen, Khaled H ^a   Hamad, Mawieh A ^a   Salah, Suleiman A ^a  

^a HASHEMITE UNIVERSITY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ADULT; AGED; ARTICLE; CANDIDA GLABRATA; CANDIDA KEFYR; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DENTURE; DIABETES MELLITUS; FEMALE; FUNGAL COLONIZATION; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; OPPORTUNISTIC INFECTION; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; THRUSH; TOBACCO;

EID: 33645291504     PISSN: 10128298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Samaranayake LP. Oral mycoses in human immunodeficiency virus infection: a review. Oral Surg Oral Med Oral Pathol 1992; 73: 171-80.
2. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J 2002; 78: 455-9.
3. Redding SW, Zellars RC, Kirkpatrick WR, et al. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 1999; 37: 3896-900.
4. Leung WK, Dassanayake RS, Yau JYY, et al. Oral colonization, phenotypic, and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors. J Clin Microbiol 2000; 38: 2219-26.
5. Aly FZ, Blackwell CC, MacKenzie DAC, et al. Identification of oral yeast species isolated from individuals with diabetes mellitus. Mycoses 1995; 38: 107-10.
6. Tapper-Jones LM, Aldred MJ, Walker DM, et al. Candidal infections and populations of Candida albicans in mouths of diabetics. J Clin Pathol 1981; 34: 706-11.
7. Abu-Elteen KH, Abu-Alteen RM. The prevalence of Candida albicans populations in the mouths of complete denture wearers. Microbiologica 1998; 21: 41-8.
8. Lamey PJ, Darwazah A, Fisher BM, et al. Secretor status, candidal carriage and candidal infection in patients with diabetes mellitus. J Oral Pathol 1988; 17: 354-7.
9. Bohannon NJV. Treatment of vulvovaginal candidiasis in patients with diabetes. Diabetes Care 1998; 21: 451-6.
10. Sobel JD. Vaginitis. New Eng J Med 1997; 337: 1896-903.
11. Reed BD. Risk factors for Candida vulvovaginitis. Obstet Gynecol Surv 1992; 47: 551-60.
12. Ajlouni K, Jaddou H, Batieha A. Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors. J Intern Med 1998; 244: 317-23.
13. Annual reports of the Ministry of Health in Jordan 1998-2003.
14. Nanetti A, Stancari F, Ferri M, et al. Relationship between Candida albicans and denture stomatitis: a clinical and microbiological study. Microbiologica 1993, 16: 287-92.
15. Al-Abeid HM, Abu-Elteen KH, Elkarmi AZ, et al. Isolation and characterization of Candida spp. in Jordanian cancer patients: prevalence, pathogenic determinants, and antifungal sensitivity. Jpn J Infect Dis 2004; 57: 279-84.
16. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994; 32: 1923-9.
17. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeast. M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA, 1997; 17(9): 1-18.
18. Leon EM, Jacober SJ, Sobel J D, et al. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis 2002; 2: 1-6.
19. Peer AK, Hoosen AA, Seedat MA, et al. Vaginal yeast infections in diabetic women. S Afr Med J 1993; 83: 727-9.
20. Darwazeh AMG, MacFarlane TW, McCuish A, et al. Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus. J Oral Pathol Med 1991; 20: 280-3.
21. Darwazeh AMG, lamey PJ, Samaranayake LP, et al. The relationship between colonization, secretor status and in-vitro adhesion of Candida albicans to buccal epithelial cells from diabetics. J Med Microbiol 1990; 33: 43-9.
22. Yarahmadi SH, Khosravi A R, Larijani B, et al. Assessment of the fungal flora and the prevalence of fungal infections in the mouth of diabetics. Irn J Endcorinol Metab 2002; 4: 14-7.
23. Neville B, Damm DD, Allen CM, et al. Oral and Maxillofacial Pathology: WB Saunders; 1995.166-9.
24. Arendorf TM, Walker DM, Kingdom RJ, et al. Tobacco smoking and denture wearing in oral candidal leucoplakia. Br Dent J 1983; 155: 340-3.
25. Rindum JL, Stenderup A, Holmstrup P. Identification of Candida albicans types related to healthy and pathological oral mucosa. J Oral Pathol Med 1994; 23: 406-12.
26. Abu-Elteen KH. Increased incidence of vulvovaginal candidiasis caused by Candida glabrata in Jordan. Jpn J Infect Dis 2001; 54: 103-7.
27. Araj GF, Daher NK, Tabbarah ZA. Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center. Int J Antimicrob Agent 1998; 10: 291-6.
28. Pfaller MA, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: Sentry antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000; 44: 747-51.
29. Martinez M, Lopez-Ribot JL, Kirkpatrick WR, et al. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidiasis. J Antimicrob Chemother 2002; 49: 515-24.